Cara Therapeutics Inc. buy HC Wainwright
Start price
15.05.24
/
50%
€0.70
Target price
15.05.25
€3.31
Performance (%)
-54.96%
Price
28.08.24
€0.32
Summary
This prediction is currently active. Massive losses of -54.96% have been the result for the BUY prediction by HC_Wainwright. This prediction currently runs until 15.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cara Therapeutics Inc. | 2.859% | 2.859% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by HC_Wainwright for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.60 price target on the stock.
Ratings data for CARA provided by MarketBeat
Stopped prediction by HC_Wainwright for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.57
19.12.23
19.12.23
€2.28
19.12.24
19.12.24
-44.26%
28.08.24
28.08.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
19.10.23
19.10.23
€6.62
19.10.24
19.10.24
-74.97%
28.08.24
28.08.24